Homocysteine lowering and cognition in CKD: the Veterans Affairs homocysteine study - Wikidata - awgldk - TriplyDB

Homocysteine lowering and cognition in CKD: the Veterans Affairs homocysteine study

Homocysteine lowering and cognition in CKD: the Veterans Affairs homocysteine study

http://www.wikidata.org/entity/Q34610179

about

Interventions for lowering plasma homocysteine levels in dialysis patients Mild cognitive impairment and dementia: the importance of modifiable risk factors Causes, Consequences and Public Health Implications of Low B-Vitamin Status in Ageing Response of serum and red blood cell folate concentrations to folic acid supplementation depends on methylenetetrahydrofolate reductase C677T genotype: Results from a crossover trial Prevalence and correlates of cognitive impairment in hemodialysis patients: the Frequent Hemodialysis Network trials.Treatment of cardiovascular risk factors to prevent cognitive decline and dementia: a systematic review.Volume of white matter hyperintensities in healthy adults: contribution of age, vascular risk factors, and inflammation-related genetic variants Chronic kidney disease and cognitive impairment: a systematic review and meta-analysis.Nutritional supplements for older adults: review and recommendations--Part II.Vascular risk factors and cognitive impairment in chronic kidney disease: the Chronic Renal Insufficiency Cohort (CRIC) study.Water-soluble vitamins in people with low glomerular filtration rate or on dialysis: a review Dementia and cognitive impairment in ESRD: diagnostic and therapeutic strategies.Genomic damage in endstage renal disease-contribution of uremic toxins Kidney disease as a determinant of cognitive decline and dementia.Cognitive dysfunction and depression in adult kidney transplant recipients: baseline findings from the FAVORIT Ancillary Cognitive Trial (FACT).25-vitamin D, 1,25-vitamin D, parathyroid hormone, fibroblast growth factor-23 and cognitive function in men with advanced CKD: a veteran population.Status of vitamins B-12 and B-6 but not of folate, homocysteine, and the methylenetetrahydrofolate reductase C677T polymorphism are associated with impaired cognition and depression in adults Dihydrofolate reductase 19-bp deletion polymorphism modifies the association of folate status with memory in a cross-sectional multi-ethnic study of adults.Dementia is a risk factor for major adverse cardiac and cerebrovascular events in elderly Korean patients initiating hemodialysis: a Korean national population-based study.COGNITIVE-HD study: protocol of an observational study of neurocognitive functioning and association with clinical outcomes in adults with end-stage kidney disease treated with haemodialysis.Frequency of and risk factors for poor cognitive performance in hemodialysis patients.Cognitive impairment and vitamin B12: a review.B-vitamins for neuroprotection: narrowing the evidence gap.Updating the relationship between hyperhomocysteinemia lowering therapy and cardiovascular events.Cognitive impairment in chronic kidney disease: clinical findings, risk factors and consequences for patient care.Chronic kidney disease-related physical frailty and cognitive impairment: a systemic review.Association of homocysteine level and vascular burden and cognitive function in middle-aged and older adults with chronic kidney disease.Chronic kidney disease and subclinical lacunar infarction are independently associated with frontal lobe dysfunction in community-dwelling elderly subjects: the Sefuri brain MRI study.Effects of carbamazepine combined with vitamin B12 on levels of plasma homocysteine, hs-CRP and TNF-α in patients with epilepsy.

P2860

Q26471859-A22688A4-9B63-4076-AA5D-DC8A6F4E1EF7 Q26994975-21D4CF47-4D37-48B3-9FA7-E8956D3BB80B Q28070413-8CF047B7-8F91-4FC5-894E-67F2D1588A8A Q29305184-7D25AE81-C252-4776-AEF2-CE16F274719F Q34075467-1B7D43D2-0630-44D1-AE9B-52204D469EEE Q34139092-AC19DA22-EF1D-484B-B628-4E7B76285DA6 Q34213287-7BFC252C-B084-4C58-82CA-5BF27CE4EC49 Q34255325-7CDCD7BB-5BFD-4BC0-A72A-39EE5E9E90D2 Q34618719-5317A8F6-C1DC-4EA1-BEF1-190B7CEEFB81 Q34639546-DE8D9051-EB98-41AD-970A-8AF0445E2090 Q34852823-D9B1BE06-CB52-4C1A-B7C5-48B48D820015 Q35021612-F406AAFC-940A-4587-8096-23FACBD88E70 Q35155634-64D99B34-8DCF-4B2E-B5D2-A969A8313A1D Q35180274-DC68424E-F491-470C-9F84-ED433AC2F1EB Q35540280-598768C2-88D8-4A61-9E8F-C2AD663EEE60 Q35949312-F0636392-68B7-4C68-90B2-36610B5BC705 Q36096343-35577468-9DA5-4244-B6EA-613773F48B88 Q36223027-4117E948-5DC9-457B-8987-9F6815CF3FB1 Q36338934-6880CC99-F7F3-4C17-ABBD-6F2A2BA0F3C9 Q36374037-33F911C3-69C8-45D1-9A8A-48E92F08656D Q36661833-764869AA-2F8D-4857-88ED-FAB35C6B58DE Q37973493-6EA28E99-B825-47A1-B9A2-3C601E05FCE1 Q37993820-8DF4C437-CDCD-4128-A9BC-22D964F1AC9E Q38053468-DD624DF1-1ADF-4989-8066-8B309F990487 Q38180990-E0B713CC-B064-47CB-B392-FAFA5EFAC709 Q38848257-BA82B417-807F-40AF-88EB-9819DF41AED5 Q38944448-FC0213D8-1CA1-4FCF-82CB-89C6C746AD81 Q49136847-33519357-13D5-48F6-BB64-BF3E77484C45 Q52643630-92772875-FE36-4D5E-BAD8-983520E5DB78

P2860

Homocysteine lowering and cognition in CKD: the Veterans Affairs homocysteine study

http://www.wikidata.org/entity/Q34610179

description

2009 nî lūn-bûn

@nan

2009 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年学术文章

@wuu

2009年学术文章

@zh-cn

2009年学术文章

@zh-hans

2009年学术文章

@zh-my

2009年学术文章

@zh-sg

2009年學術文章

@yue

name

Homocysteine lowering and cognition in CKD: the Veterans Affairs homocysteine study

@ast

Homocysteine lowering and cognition in CKD: the Veterans Affairs homocysteine study

@en

Homocysteine lowering and cognition in CKD: the Veterans Affairs homocysteine study

@nl

type

label

Homocysteine lowering and cognition in CKD: the Veterans Affairs homocysteine study

@ast

Homocysteine lowering and cognition in CKD: the Veterans Affairs homocysteine study

@en

Homocysteine lowering and cognition in CKD: the Veterans Affairs homocysteine study

@nl

prefLabel

Homocysteine lowering and cognition in CKD: the Veterans Affairs homocysteine study

@ast

Homocysteine lowering and cognition in CKD: the Veterans Affairs homocysteine study

@en

Homocysteine lowering and cognition in CKD: the Veterans Affairs homocysteine study

@nl

P1433

Q34610179-CC6A74E0-A8A0-4263-BFF0-BC49061B050E

P1476

Q34610179-D9D63043-F73B-454E-A9D2-BF43D738F7B8

P2093

Q34610179-112961E7-4267-4568-9CD2-CDC107EDD999

Q34610179-4E713F56-A422-4A78-AD03-7F13B8CDDD8C

Q34610179-6B73B652-C331-44BE-B931-374F5BDC9C4E

Q34610179-6C427AD3-8EE0-4812-BB72-9BA203110A19

Q34610179-80D3FFFB-C164-44F8-A3B5-6A3021DBAC24

Q34610179-96424DC1-D198-42C3-BD91-B666B650B143

Q34610179-FBDA089C-0FE7-4D74-B8B7-2E51A9ABDB00

P2860

Q34610179-01A06A8C-65D2-4BD6-9F53-C318A238F7BF

Q34610179-07C8CD4B-65DC-4086-A5F5-B6B7CC570121

Q34610179-0FFFEDA7-1316-4F2D-AB5B-C10E63925E74

Q34610179-16D14579-3B02-4DD1-9CCE-CFF2D77D2839

Q34610179-2B3D5F90-91E9-4C3D-8EE6-1DCF1A5B23D8

Q34610179-2D72980F-2D33-4001-87EF-801DB933E64C

Q34610179-369BC8BF-F76A-470B-9349-1B6D38BCC286

Q34610179-38383D63-6E01-4EDB-8D62-07629EDA6EF2

Q34610179-3A28EC82-48D2-4BFF-B517-21DFC5AA04F1

Q34610179-3CA570FC-562C-4961-8B87-C80C28FA1A81

P304

Q34610179-F5E49274-7164-4D71-8199-2F6C1BA26670

P31

Q34610179-94CBED77-B07F-4FD2-B766-45D11160DA06

P356

Q34610179-8E0882AF-09A7-4638-B63B-55A0EAA1A608

P433

Q34610179-EFB676E5-FF50-4E10-BBCB-CC2004558B96

P478

Q34610179-D88D8C34-849C-4DA1-A1A2-8EABF6B95210

P50

Q34610179-3CFB5B93-9A17-4EAF-9AA9-956C45A664E6

Q34610179-7C55DF6D-F607-4A00-BF61-AE8D05FB200D

P577

Q34610179-A27610F2-C2DC-40CA-B537-4F2DC2D7FECA

P5875

Q34610179-C195BDE2-889B-4D05-B9F1-7F12395BC797

P698

Q34610179-05E042EF-B643-42C4-ABC2-C4E7FB13C8EC

P921

Q34610179-BFD40CD1-BCD7-4A8A-9323-57BA4CE86276

P932

Q34610179-317AD5A9-9C70-4F48-B092-5EC7C625F78E

P356

J.AJKD.2009.05.013

P1433

American Journal of Kidney Diseases

P1476

Homocysteine lowering and cognition in CKD: the Veterans Affairs homocysteine study

@en

P2093

J Michael Gaziano

http://www.w3.org/2001/XMLSchema#string

James S Kaufman

http://www.w3.org/2001/XMLSchema#string

Pamela Hartigan

http://www.w3.org/2001/XMLSchema#string

Peter D Guarino

http://www.w3.org/2001/XMLSchema#string

Rex L Jamison

http://www.w3.org/2001/XMLSchema#string

Roberta A Cxypoliski

http://www.w3.org/2001/XMLSchema#string

Stuart R Warren

http://www.w3.org/2001/XMLSchema#string

P2860

Validation of multi-stage telephone-based identification of cognitive impairment and dementia.

Homocysteine and cognitive decline in healthy elderly

Prediction of creatinine clearance from serum creatinine

Development and validation of a geriatric depression screening scale: a preliminary report

Plasma homocysteine as a risk factor for dementia and Alzheimer's disease.

Effect of 3-year folic acid supplementation on cognitive function in older adults in the FACIT trial: a randomised, double blind, controlled trial.

The kidney and homocysteine metabolism.

Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial.

Effect of homocysteine lowering on mortality and vascular disease in advanced chronic kidney disease and end-stage renal disease: a randomized controlled trial.

High-dose B vitamin supplementation and cognitive decline in Alzheimer disease: a randomized controlled trial.

P304

440-449

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1053/J.AJKD.2009.05.013

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

54

http://www.w3.org/2001/XMLSchema#string

P50

David S Goldfarb

Christopher B Brady

P577

2009-07-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26691610

http://www.w3.org/2001/XMLSchema#string

P698

19628319

http://www.w3.org/2001/XMLSchema#string

P921

P932

2748786

http://www.w3.org/2001/XMLSchema#string